Skip to main content
Journal cover image

Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer

Publication ,  Conference
Chino, F; Castellar, EP; Schild, M; Blitzblau, RC; Georgiade, G; Suneja, G; Duffy, E; Broadwater, G; Horton, JK
Published in: International Journal of Radiation Oncology*Biology*Physics
October 2017

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

October 2017

Volume

99

Issue

2

Start / End Page

E9 / E9

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chino, F., Castellar, E. P., Schild, M., Blitzblau, R. C., Georgiade, G., Suneja, G., … Horton, J. K. (2017). Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer. In International Journal of Radiation Oncology*Biology*Physics (Vol. 99, pp. E9–E9). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2017.06.611
Chino, F., E. P. Castellar, M. Schild, R. C. Blitzblau, G. Georgiade, G. Suneja, E. Duffy, G. Broadwater, and J. K. Horton. “Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 99:E9–E9. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.611.
Chino F, Castellar EP, Schild M, Blitzblau RC, Georgiade G, Suneja G, et al. Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017. p. E9–E9.
Chino, F., et al. “Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer.” International Journal of Radiation Oncology*Biology*Physics, vol. 99, no. 2, Elsevier BV, 2017, pp. E9–E9. Crossref, doi:10.1016/j.ijrobp.2017.06.611.
Chino F, Castellar EP, Schild M, Blitzblau RC, Georgiade G, Suneja G, Duffy E, Broadwater G, Horton JK. Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017. p. E9–E9.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

October 2017

Volume

99

Issue

2

Start / End Page

E9 / E9

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences